Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Biju Azariah"'
Autor:
Biju Azariah M, Arumugam Velappan
Publikováno v:
Asian Journal of Medical Sciences, Vol 15, Iss 11, Pp 65-69 (2024)
Background: Breast cancer is widely studied for its psychosomatic aspects owing to its high prevalence among women and the impact of chronic life stressors on its development and outcomes. Aims and Objectives: This study aimed to evaluate the asso
Externí odkaz:
https://doaj.org/article/2e507c4e2fbf4ccba6efc3367cd3eb64
Autor:
M., Biju Azariah1, Velappan, Arumugam2 arumugamonco@gmail.com
Publikováno v:
Asian Journal of Medical Sciences. Nov2024, Vol. 15 Issue 11, p65-69. 5p.
Publikováno v:
Journal of Cancer Research and Therapeutics.
Autor:
Geethu Babu, Biju Azariah
Publikováno v:
Scholars Journal of Medical Case Reports. 9:702-706
Work related musculoskeletal disorders (WRMSDs) have not only shown to impact the physical and pschycological comfort of the employee but also deteriorate the prospects of any production or service sector. The prevalence of WRMSDs, though studied ext
Publikováno v:
Scholars Journal of Medical Case Reports. 9:690-695
Granulosa cell tumors constitute less than 5 % of all ovarian tumors. Unlike epithelial ovarian tumors, they occur in a younger age group, are usually detected in an early stage and often have features of hyperestrogenism. They follow an indolent cou
Publikováno v:
Scholars Journal of Medical Case Reports. 9:657-662
Placental site trophoblastic tumor (PSTT), a rare form of gestational trophoblastic disease (GTD) has a wide clinical and biological spectrum with benign to malignant potential. PSTT can occur after any type of pregnancy and no specific risk factors
Publikováno v:
Scholars Journal of Medical Case Reports. 8:825-828
Autor:
Sharika V Menon, M Biju Azariah, Seetha Mohandas, Susan Mathews, P.G. Jayaprakash, Preethi George
Publikováno v:
Journal of Cancer Research and Therapeutics, Vol 15, Iss 6, Pp 1332-1337 (2019)
Purpose: The purpose of this study was to evaluate the doses delivered to the brachytherapy (BT) target volume and organs at risk from two-dimensional X-ray-based plans on magnetic resonance imaging (MRI) and to compare these doses with the correspon
Autor:
Ian F. Tannock, C S Pramesh, Richard Sullivan, Wilma M. Hopman, Joseph C Del Paggio, Biju Azariah, Christopher M. Booth, Deborah Schrag
Publikováno v:
The Lancet Oncology. 18:887-894
Summary Background The American Society of Clinical Oncology (ASCO) and the European Society for Medical Oncology (ESMO) have developed frameworks that quantify survival gains in light of toxicity and quality of life to assess the benefits of cancer
Autor:
Biju Azariah, Wilma M. Hopman, Ian F. Tannock, Joseph C Del Paggio, C.S. Pramesh, Richard Sullivan, Deborah Schrag, Christopher M. Booth
Publikováno v:
Journal of Clinical Oncology. 35:6609-6609
6609 Background: ASCO and ESMO have developed frameworks to evaluate the benefit of cancer therapies. Here, we apply the frameworks to a cohort of contemporary randomized controlled trials (RCTs) to explore agreement and to evaluate the relationship